Clinical Trials Logo

Clinical Trial Summary

Interstitial lung diseases (ILD) in children represent a heterogeneous group of rare and not well defined disorders. Genetic abnormalities of surfactant proteins B (SFTPB) and more recently C (SFTPC) have been shown to be related to these pathologies. However, variability in the lung disease phenotype suggests the involvement of other surfactant-associated genes such as ABCA3 (ATP-binding cassette, sub-family A, member, 3). Thus, the aim of this project is: 1) to assess the prevalence of SFTPC mutation in children with chronic lung diseases, 2) to precise clinical and radiological features of children with SFTPC mutation, and 3) to identify environmental or genetic factors that may explain the extreme variability of this disease.


Clinical Trial Description

The first stage of this project will be to constitute a clinical, radiological, biological database of children (1 moth-17 years) with severe respiratory distress and/or an unexplained chronic ILD. Mutations in SFTPC, SFTPB and ABCA3 will be further identified by sequencing and documented with using the parents blood samples. ;


Study Design

Observational Model: Family-Based, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT00783978
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Completed
Phase N/A
Start date September 2009
Completion date June 2012

See also
  Status Clinical Trial Phase
Completed NCT04037436 - Functional Exercise and Nutrition Education Program for Older Adults N/A
Active, not recruiting NCT04663685 - MoveStrong at Home N/A
Recruiting NCT06112730 - Nutritional Supplementation in Patients With Chronic Respiratory Disease N/A
Not yet recruiting NCT03180164 - Depression in Chronic Airways Diseases N/A
Completed NCT02544984 - The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease N/A
Recruiting NCT01721655 - Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease Phase 2/Phase 3
Completed NCT00233064 - Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) Phase 4
Recruiting NCT05866302 - Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
Not yet recruiting NCT06326957 - Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE) N/A
Completed NCT01326611 - Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants Phase 4
Not yet recruiting NCT05025774 - Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
Completed NCT05776264 - Exercise Strategies to Motivate and Relieve Stress N/A
Completed NCT03773991 - Dyspnea Assessment in Hemodialysis Patients
Completed NCT02055339 - Pilot Study Comparing Different Modes of Non-invasive Ventilation for the Oral Feeding of Preterm Infants N/A
Withdrawn NCT03673566 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO N/A
Completed NCT02426112 - Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children Phase 3
Recruiting NCT00710112 - Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
Withdrawn NCT03673579 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB N/A
Active, not recruiting NCT03018717 - Integral Clinical Plan Shared With or Without Telemonitoring of Constants in Patient With Chronic Diseases N/A
Completed NCT03385330 - BPD Saturation TARgeting N/A